# A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients

> **NCT00979771** · PHASE2 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** GSK706769
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00979771
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-02-01
- **Primary completion:** 2011-04-28
- **Final completion:** 2011-04-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Cancelled Before Active
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979771, "A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00979771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*